Serologic Procedures And Test Methodology

Antigen-Antibody Reactions

Serologic detection depends on antibody binding antigen to form a visible complex. The zone of equivalence is the optimal antigen-to-antibody ratio where maximal cross-linking (lattice) and visible reaction occur.

• Antibody excess (prozone): too much antibody coats individual antigens without bridging them → false-negative.
• Antigen excess (postzone): too much antigen, not enough antibody to cross-link → false-negative.

The prozone phenomenon (also called the high-dose hook effect) is a classic exam trap: a strongly positive sample reads falsely negative because of antibody excess. Diluting the specimen moves the ratio into the zone of equivalence and reveals the true positive. RPR testing and pregnancy/tumor-marker assays are common settings.

Precipitation Versus Agglutination

Agglutination is more sensitive than precipitation because particulate antigens make smaller amounts of antibody visibly clump. Direct agglutination uses naturally particulate antigen; passive (indirect) agglutination coats a carrier particle (latex bead) with antigen or antibody.

Labeled-Immunoassay Methods

Modern serology is dominated by labeled assays that amplify detection.

• Enzyme immunoassay (EIA/ELISA): an enzyme label (e.g., horseradish peroxidase, alkaline phosphatase) converts substrate to a colored product. In a sandwich assay, antigen is captured between two antibodies; in a competitive assay, signal is inversely proportional to analyte. ELISA is the workhorse for HIV and hepatitis screening.
• Chemiluminescent immunoassay (CLIA): label emits light; high sensitivity and full automation; common on infectious-disease and hormone analyzers.
• Immunofluorescence: a fluorochrome (fluorescein) label is read under a fluorescent microscope. Direct (DFA) detects antigen in a specimen; indirect (IFA) detects patient antibody (used for the ANA HEp-2 test).
• Nephelometry / turbidimetry: measures light scattered or blocked by immune complexes in solution to quantitate proteins such as immunoglobulins and complement.

Test Performance Statistics

Understanding assay validity is a named theoretical skill. Build the 2×2 table of test result versus true disease state.

• Sensitivity = TP / (TP + FN): ability to detect those who truly have the disease. A highly sensitive test, when negative, rules disease out.
• Specificity = TN / (TN + FP): ability to correctly identify those without disease. A highly specific test, when positive, rules disease in.
• Positive predictive value (PPV) = TP / (TP + FP) and negative predictive value (NPV) = TN / (TN + FN) — both depend on disease prevalence.

Design logic: screening tests (RPR, ANA, fourth-generation HIV) are built for high sensitivity (catch every true case, accept some false positives); confirmatory tests (treponemal assays, HIV differentiation immunoassay, anti-dsDNA) are built for high specificity.

High-Yield Traps

• A prozone false-negative is corrected by diluting the sample, not by repeating it undiluted.
• Agglutination is more sensitive than precipitation; choose it when small antibody amounts must be detected.
• A highly sensitive test is best for ruling out disease when negative; a highly specific test is best for ruling in disease when positive.
• Predictive values shift with prevalence; a positive screen in a low-prevalence population has a low PPV.

Complement-Based And Cellular Methods

Some serologic methods exploit the complement cascade or detect cells directly. Complement fixation assays, now largely historical, measure whether patient antibody consumes complement. The direct and indirect antiglobulin tests (DAT and IAT, the Coombs tests) use anti-human globulin reagent to detect antibody or complement already bound to red cells (DAT) or antibody in serum that will bind reagent cells (IAT) — a bridge between immunology and blood banking that the MLS exam often blends.

Flow cytometry uses fluorochrome-labeled monoclonal antibodies to count and characterize cells; it is the standard method for CD4 enumeration in HIV and for leukemia/lymphoma immunophenotyping.

Quantitation, Standards, And Controls

Quantitative immunoassays compare patient signal against a calibration (standard) curve built from known concentrations. A sandwich (capture) EIA gives signal proportional to analyte, while a competitive EIA gives signal inversely proportional to analyte — reversing this relationship is a frequent error. Method validity rests on running positive and negative controls with every batch; a control that falls outside its acceptable range invalidates the run regardless of how reasonable patient results appear.

Choosing And Interpreting A Method

Method selection follows the clinical question, and the exam tests this matching directly.

Worked example: A laboratory must report a numeric IgG concentration on a patient with suspected hypogammaglobulinemia. Nephelometry measures light scattered by soluble immune complexes in solution and yields a quantitative protein concentration, making it the correct method; an agglutination card would give only a qualitative result and indirect immunofluorescence is designed for autoantibody patterns, not protein quantitation. Matching the method to whether the answer must be qualitative, semi-quantitative, or fully quantitative is the core procedural skill in this section.

Additional Traps

• Competitive immunoassay signal is inversely related to analyte; sandwich assay signal is directly related.
• The DAT detects antibody already on the patient's red cells; the IAT detects antibody in serum.
• Flow cytometry, not ELISA, is the method for CD4 counting and immunophenotyping.
• A failed batch control invalidates all patient results in that run.